MEI Pharma, Inc.
MEIP
$2.10
$0.062.94%
NASDAQ
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | -60.09% | -67.27% | -61.92% | -49.52% | -52.10% |
Total Receivables | -- | -- | -- | -- | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | -- | -- | -77.17% | -27.23% | 87.56% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -36.12% | -- | -- |
Total Current Assets | -63.15% | -68.62% | -62.09% | -50.73% | -50.41% |
|
|||||
Total Current Assets | -63.15% | -68.62% | -62.09% | -50.73% | -50.41% |
Net Property, Plant & Equipment | -- | -99.96% | -95.44% | -13.21% | -12.63% |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -- | -- | -- | -- | -- |
Total Assets | -68.95% | -72.59% | -65.75% | -46.90% | -46.79% |
|
|||||
Total Accounts Payable | -56.75% | -69.69% | -48.35% | -27.64% | -66.12% |
Total Accrued Expenses | -70.04% | -55.79% | -58.37% | -66.87% | -60.65% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -- | -- | -- | -24.04% | -24.42% |
Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
Total Other Current Liabilities | -- | -- | -- | -- | -- |
Total Current Liabilities | -71.55% | -66.46% | -58.92% | -59.29% | -64.52% |
|
|||||
Total Current Liabilities | -71.55% | -66.46% | -58.92% | -59.29% | -64.52% |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -- | -- | -- | -9.02% | -8.44% |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | -87.99% | -85.56% | -91.31% | -79.74% | -80.80% |
|
|||||
Common Stock & APIC | 0.20% | -2.29% | -2.18% | -2.20% | -2.04% |
Retained Earnings | -10.60% | -13.33% | 4.38% | 6.61% | 5.21% |
Treasury Stock & Other | -- | -- | -- | -- | -- |
Total Common Equity | -62.85% | -69.42% | 34.10% | 48.54% | 22.98% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | -62.85% | -69.42% | 34.10% | 48.54% | 22.98% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -62.85% | -69.42% | 34.10% | 48.54% | 22.98% |
|